CRRTF - Crescita Therapeutics GAAP EPS of -C$0.01 revenue of C$5.2M
2023-08-09 12:45:30 ET
- Crescita Therapeutics press release ( OTCPK:CRRTF ): Q2 GAAP EPS of -C$0.01.
- Revenue of C$5.2M (-20.1% Y/Y).
- Segment revenue is expected to be materially lower in the second half of 2023.
For further details see:
Crescita Therapeutics GAAP EPS of -C$0.01, revenue of C$5.2M